Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b study
Kelly G. Paulson,Sally C. M. Lau,Myung‐Ju Ahn,Mor Moskovitz,Michael Pogorzelski,Simon Häfliger,Amanda Parkes,Yuyang Zhang,Ali Hamidi,Corbin G. Thompson,Martin Wermke
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
风吹麦田
大力的灵雁
dew
无糖加冰
tiptip
Zzz
Zac
殷勤的紫槐
乐观秋荷
昏睡的蟠桃
pluto
乐空思
这杯酒名忘情
畔畔
lizishu
你嵙这个期刊没买
Alexa
ySX
微尘
皖公网安备34019202002308